Prosecution Insights
Last updated: April 19, 2026

New England Biolabs Inc.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
0
Final Rejections
8
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18969910 Programmable Cleavage of RNA REGA, KYLE THOMAS 1636 Non-Final OA Dec 05, 2024
18562953 An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase SALMON, KATHERINE D 1682 Non-Final OA Nov 21, 2023
18356052 Polynucleotide Error Recognition Methods and Compositions HUTSON, RICHARD G 1652 Non-Final OA Jul 20, 2023
18323143 Double-Stranded DNA Deaminases and Uses Thereof BUCHANAN, BAILEY CHEYENNE 1682 Non-Final OA May 24, 2023
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 1798 Non-Final OA Jan 18, 2023
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 1683 Non-Final OA Sep 27, 2022
17820372 Rolling Circle Reverse Transcription of Circular RNA LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Aug 17, 2022
17825346 Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides ZHANG, KAIJIANG 1684 Non-Final OA May 26, 2022

Managing New England Biolabs Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month